CRP and systemic sclerosis: Specifically, we aimed to: (1) determine whether RV MPI is elevated in patients with SSc relative to controls; (2) examine correlations between RV MPI and disease parameters, including C-reactive protein (CRP) as a marker of inflammation, the modified Rodnan skin score as a measure of skin fibrosis, pulmonary function tests [forced vital capacity (FVC) and FEV1/FVC ratio], and SSc-specific autoantibodies; and (3) perform subgroup analyses of RV MPI in diffuse cutaneous vs. limited cutaneous SSc, stratified by antibody status [anti-topoisomerase I (Scl-70) vs. anti-centromere antibodies].